# A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)

> **NCT07044479** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Enlicitide

## Key facts

- **NCT ID:** NCT07044479
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-03
- **Primary completion:** 2025-08-13
- **Final completion:** 2025-08-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07044479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07044479, "A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07044479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*